CELEX: 62014TB0620
Language: en
Date: 2015-09-16 00:00:00
Title: Case T-620/14: Order of the General Court of 16 September 2015 — Diapharm v Commission (Action for failure to act — Consumer protection — Health claims made on foods — Regulation (EC) No 1924/2006 — Botanical substances — Time-limit for bringing an action — No legal interest in bringing proceedings — Act not amenable to review — Inadmissibility)

16.11.2015   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 381/33
            
         Order of the General Court of 16 September 2015 — Diapharm v Commission
   (Case T-620/14) (1)
   
   ((Action for failure to act - Consumer protection - Health claims made on foods - Regulation (EC) No 1924/2006 - Botanical substances - Time-limit for bringing an action - No legal interest in bringing proceedings - Act not amenable to review - Inadmissibility))
   (2015/C 381/37)
   Language of the case: German
   
      Parties
   
   
      Applicant: Diapharm GmbH & Co. KG (Münster, Germany) (represented by: M. Weidner, N. Hußmann and T. Guttau, lawyers)
   
      Defendant: European Commission (represented by: M. Wilderspin and S. Grünheid, acting as Agents)
   
      Re:
   
   Application seeking a declaration that the Commission failed to act in that it unlawfully refrained from ordering the European Food Safety Authority (EFSA) to evaluate the health claims relating to botanical substances as a condition prior to the adoption of the definitive list of authorised health claims in accordance with Article 13(3) of Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods (OJ 2006 L 404, p. 9).
   
      Operative part of the order
   
   
               1.
            
            
               The action is dismissed as inadmissible.
            
         
               2.
            
            
               Diapharm GmbH & Co. KG shall pay the costs.
            
         
      (1)  OJ C 409, 17.11.2014.